Promega signed a license agreement with BrainXell, a Madison-based producer of iPSC-derived human cells such as neurons and glia, the company announced today. “Reporter-enabled human neural models take expertise that…
The U.S. Food and Drug Administration (FDA) approved the Promega OncoMate® MSI Dx Analysis System designed to identify patients with microsatellite high (MSI-H) solid tumors as a companion diagnostic designed…
In 2025, the biohealth industry in Wisconsin contributed $38.1 billion in total economic activity, according to the Wisconsin Biohealth Industry Landscape and Economic Impact Report. In addition, the industry directly…
NorthStar Medical Technologies and NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, announced recently a long-term strategic partnership under which NorthStar will produce Copper-67 (Cu-67) and provide comprehensive radiopharmaceutical manufacturing services to…
NorthStar Medical Technologies is partnering with Quarkmed, a Beijing-based contract research organization (CRO) specializing in nuclear medicine and radiopharmaceutical clinical development, the company announced today. According to a release, Quarkmed…
Forward BIOLABS, in partnership with BioForward Madison, announced today the second round of awardees of the Innovation to Commercialization Pipeline (ICP) program. The awardees from the Madison area are aMBR…
Arkayli Biopharma, a biopharmaceutical company developing innovative therapies for rare dermatologic conditions, announced today that it has received a Study May Proceed (SMP) letter from the U.S. Food and Drug…
NorthStar Medical Technologies announced today a multi-year growth capital facility of up to $185 million from Hercules Capital for continued growth and expansion. According to a release, the financing will…
Elephas Biosciences and Tes Pharma, an Italy-based biopharmaceutical company focused on developing therapeutics for unmet medical needs, announced today that they are collaborating to advance translational research for lung therapy….
Stem Pharm received a $2.5 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), the…
